Contract BT21
Amerisourcebergen Drug Corp · Department Of Defense · October 28, 1999
Amerisourcebergen Drug Corp was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on October 28, 1999 for $3.85 million of work in medicinal and botanical manufacturing. Performance is in Chesterbrook, PA. This is a task or delivery order issued under parent IDIQ SPE2DX15D3002. The contract has been modified 211 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 27, 2017.
Contract details
- PIID
- BT21
- Parent IDIQ
- SPE2DX15D3002
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- October 28, 1999
- Latest action
- November 27, 2017
Description
4540108058!TRICARE WEST
Modification timeline
-
November 27, 2017Base award$295
-
September 26, 2017Base award4539475891!TRBO REGION 3$1.3K
-
September 8, 2017Base award4539265981!TRBO REGION 1$3.3K
-
September 6, 2017Base award4539233846!TRBO REGION 1$1.2K
-
September 1, 2017Base award4539199207!TRBO REGION 1$1.1K
-
September 1, 2017Base award4539189449!TRICARE WEST$27
-
August 29, 2017Base award4539146912!TRBO REGION 1$780
-
August 28, 2017Base award4539137071!TRBO REGION 1$441
-
August 28, 2017Base award4539133384!PHARM PRIME VENDOR FLEET$3.4K
-
August 23, 2017Base award4539086275!TRBO REGION 3$70
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract BT21?
Contract BT21 is a federal contract awarded to Amerisourcebergen Drug Corp by Department Of Defense on October 28, 1999 for $3.85 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 211 times since the base award.
Who won contract BT21?
Amerisourcebergen Drug Corp won contract BT21 from Department Of Defense.
How much is contract BT21 worth?
Contract BT21 has obligated $3.85 million to date.